跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 734 条关于
“Xoma Royalty”
全部
734
临床试验
213
药物
36
机构
87
资讯
398
9个月前
XOMA Royalty Completes $2.035 Per Share Acquisition of Mural Oncology
去年
XOMA Royalty Acquires Pulmokine for $20 Million, Expanding PAH Portfolio with Seralutinib
去年
XOMA Royalty Reports Q3 2024 Financial Results, Highlights Portfolio Expansion
去年
XOMA Royalty Acquires Mural Oncology for $36.2 Million in Strategic Biotech Consolidation
去年
XOMA Royalty Expands Portfolio to Over 120 Assets, Reports Financial Results for 2024
10个月前
XOMA Royalty Reports Strong Q3 2025 Results with Multiple Strategic Acquisitions and Key Pipeline Milestones
去年
XOMA Royalty Corporation to Acquire Turnstone Biologics for $0.34 Per Share Plus Contingent Value Rights
去年
XOMA Royalty Acquires $30 Million Mezagitamab Rights from BioInvent as Anti-CD38 Antibody Advances to Phase 3
去年
XOMA Royalty Reports Q3 2024 Financial Results, Highlights MIPLYFFA™ Approval
9个月前
Xoma Royalty Acquires Gene Therapy Developer Generation Bio for $4.29 Per Share
第 1 页,共 40 页
上一页
下一页